asthma in pediatric patient - Nursing Case Study
Pathophysiology
• Primary mechanism: In asthma, airway inflammation is the central issue. In pediatric patients, exposure to allergens or irritants triggers an immune response, leading to the release of inflammatory mediators like histamines and leukotrienes. This results in swelling and increased mucus production, narrowing the airways.
• Secondary mechanism: Bronchoconstriction is another critical factor. The smooth muscles surrounding the airways contract excessively in response to the inflammatory process, further restricting airflow and causing difficulty in breathing.
• Key complication: Chronic inflammation can lead to airway remodeling, where structural changes in the airway occur over time, potentially leading to persistent asthma symptoms and decreased lung function if not adequately managed.
Patient Profile
Demographics:
10-year-old female, student
History:
• Key past medical history: Diagnosed with asthma at age 5; history of seasonal allergies
• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased shortness of breath and coughing
• Key symptoms: Wheezing, chest tightness, persistent dry cough, fatigue
• Vital signs: Temperature 98.9°F, Heart rate 110 bpm, Respiratory rate 30 breaths/min, Blood pressure 110/70 mmHg, Oxygen saturation 92% on room air
Section 1
As the healthcare team continues to monitor the 10-year-old patient, a change in her status becomes evident. Despite the administration of her Albuterol inhaler, her symptoms persist, and her oxygen saturation has dropped to 89% on room air. Her respiratory rate increases to 35 breaths per minute, indicating increased respiratory distress. The wheezing is now audible without a stethoscope, and she is using accessory muscles to breathe. Her heart rate remains elevated at 115 bpm, and she appears increasingly fatigued, with dark circles under her eyes and pale skin.
Given these changes, the medical team decides to perform a chest X-ray and order blood tests to further evaluate her condition. The chest X-ray reveals hyperinflation of the lungs, consistent with asthma exacerbation, but also suggests the possibility of a developing secondary infection, such as pneumonia, given the presence of patchy infiltrates. Blood tests show an elevated white blood cell count and increased eosinophil levels, indicating an ongoing inflammatory response and potential allergic component.
The team is now faced with the challenge of managing not only the acute asthma exacerbation but also addressing the possible secondary bacterial infection. The decision is made to initiate a course of oral corticosteroids to reduce inflammation and consider starting antibiotics, taking into account her penicillin allergy. Further, her inhaled corticosteroid dosage may need adjustment to prevent future exacerbations. This situation requires careful clinical reasoning to balance treatment effectiveness with potential side effects, and to reassess her asthma management plan to prevent further complications. The team will closely monitor her response to the interventions, adjusting the plan as necessary based on her clinical progress.
Section 2
As the medical team implements the treatment plan, they keenly observe the patient's response to interventions, starting with the initiation of oral corticosteroids and adjusting her inhaled corticosteroid dosage. Over the next 12 hours, the healthcare team notes some encouraging signs. The patient's respiratory rate begins to stabilize, dropping to 28 breaths per minute, and her use of accessory muscles diminishes slightly, suggesting a reduction in respiratory distress. Her oxygen saturation improves to 93% on supplemental oxygen, indicating a positive response to the corticosteroid therapy. However, her heart rate remains elevated at 110 bpm, possibly due to the stress of the situation and medication effects.
Despite these improvements, the patient's clinical picture remains concerning. She continues to exhibit audible wheezing and displays signs of fatigue, struggling to maintain her energy levels. The team also notes that she has developed a low-grade fever of 100.5°F, which raises suspicion that the secondary bacterial infection may be taking hold. Given her penicillin allergy, the decision is made to initiate a course of azithromycin, a macrolide antibiotic, to target the suspected pneumonia while minimizing the risk of an allergic reaction.
The continued presence of patchy infiltrates on the chest X-ray and the elevated white blood cell count emphasize the need for vigilant monitoring and possible adjustments to the treatment plan. The team discusses the importance of reassessing her response to the antibiotics within the next 24 to 48 hours, emphasizing the need for a multidisciplinary approach to manage both the asthma exacerbation and the potential infection. This requires clinical reasoning to evaluate whether the interventions are achieving the desired outcomes and to anticipate any further complications that may arise, ensuring the patient's safety and progression towards recovery.
Section 3
As the medical team continues to manage the pediatric patient's condition, they note a change in her status that warrants immediate attention. Over the next 24 hours, the patient's respiratory status shows signs of regression. Her respiratory rate begins to climb again, reaching 34 breaths per minute, and her oxygen saturation drops to 90% despite supplemental oxygen. The audible wheezing becomes more pronounced, and her use of accessory muscles intensifies, indicating increased respiratory effort. The patient's fatigue has worsened, and she appears more lethargic, raising concerns about her overall energy reserves and ability to maintain adequate ventilation.
Alongside these respiratory changes, new diagnostic results reveal concerning trends. A repeat chest X-ray shows an increase in the extent of patchy infiltrates, suggesting that the suspected pneumonia may not be fully responding to the current antibiotic regimen. Blood tests indicate a further rise in the white blood cell count to 16,000/mm³, which is consistent with an ongoing inflammatory response. Additionally, her C-reactive protein (CRP) level is elevated, further supporting the presence of an active infection. These findings prompt the healthcare team to reconsider the effectiveness of the current treatment plan, particularly regarding the antibiotic coverage.
Given the patient's deteriorating respiratory status and the potential for complications such as respiratory failure or sepsis, the team convenes to discuss potential modifications to the treatment strategy. This includes considering a broader spectrum antibiotic or adding a second agent to cover atypical pathogens. The team also evaluates the need for escalation of respiratory support, possibly transitioning to a higher level of care such as non-invasive ventilation if her condition does not improve. These decisions require careful clinical reasoning, balancing the risks and benefits of each intervention while closely monitoring the patient's response to ensure stabilization and recovery.
Section 4
As the healthcare team shifts focus to address the deteriorating condition of the pediatric patient, they initiate a comprehensive reassessment to guide their next steps. The primary concern is her respiratory status, which continues to decline despite the current interventions. Upon examination, her vital signs reveal an increased heart rate of 140 beats per minute, indicative of compensatory tachycardia due to hypoxia. Her blood pressure remains stable at 100/60 mmHg, but the persistent tachypnea, with respiratory rates now climbing to 38 breaths per minute, suggests impending respiratory fatigue. Physical assessment confirms the increased use of accessory muscles, nasal flaring, and paradoxical breathing patterns, all of which are alarming signs of significant respiratory distress.
The team decides to order an arterial blood gas (ABG) analysis to further evaluate her ventilatory status. The results show a pH of 7.32, indicating acidosis, a partial pressure of carbon dioxide (PaCO2) of 50 mmHg, demonstrating hypercapnia, and a partial pressure of oxygen (PaO2) of 55 mmHg, confirming hypoxemia. These findings suggest a trend towards respiratory acidosis, likely due to the patient’s inability to effectively clear carbon dioxide as her fatigue worsens. This data, coupled with the elevated inflammatory markers and worsening infiltrates on the chest X-ray, supports the need for a more aggressive intervention strategy.
Given the current clinical picture, the team deliberates on advancing respiratory support. The decision is made to initiate continuous positive airway pressure (CPAP) therapy to improve alveolar ventilation and oxygenation. Concurrently, they adjust the antibiotic regimen to include a broader-spectrum agent, such as a macrolide, to address potential atypical pathogens contributing to the inadequate response. The patient’s close monitoring becomes paramount, with the team preparing to escalate to more invasive measures, like intubation, should she show no improvement. The objective is to stabilize her condition, prevent further complications like respiratory failure, and ensure a trajectory towards recovery.
Section 5
As the healthcare team continues to monitor the pediatric patient under CPAP therapy, they remain vigilant for any indicators of improvement or further decline. Over the next few hours, the patient's respiratory rate remains elevated at 36 breaths per minute, but there is a slight decrease in accessory muscle use, suggesting a marginal relief in respiratory distress. However, her heart rate remains high at 138 beats per minute, which, coupled with intermittent desaturation episodes with oxygen levels dropping to 88%, prompts the team to reassess her current status comprehensively.
A repeat arterial blood gas analysis is conducted to evaluate the effectiveness of CPAP therapy. The new ABG results reveal a slightly improved pH of 7.35, indicating a mild correction of acidosis. However, the partial pressure of carbon dioxide (PaCO2) remains elevated at 48 mmHg, and the partial pressure of oxygen (PaO2) has only marginally improved to 60 mmHg. These values suggest that while there is some improvement, the patient is still struggling with ventilation and oxygenation.
During this period, the team also notices an increase in the patient's restlessness and irritability, which could be due to hypoxia or the discomfort associated with CPAP. A follow-up chest X-ray shows persistent infiltrates with no significant resolution, raising concerns about possible secondary complications such as pneumonia or an underlying infectious process. These findings prompt the clinical team to consider additional interventions, such as bronchodilator therapy adjustments and further escalation of respiratory support if necessary. The team's goal remains to stabilize the patient and prevent progression to respiratory failure, requiring continuous assessment and timely responses to her evolving condition.